Web17 Mar 2024 · The FDA has issued a Class I recall for Smiths Medical CADD infusion system Administration Sets and Cassette Reservoirs. The recall impacts 19,792,933 devices distributed in the U.S. from June 15, 2024 to the present. CADD ambulatory infusion systems deliver controlled amounts of medications to patients in hospital, outpatient, and home … WebRecall of CADD ADMINISTRATION SET Manufacturer SMITHS MEDICAL ASD INC. Manufacturer Address ST-PAUL Manufacturer Parent Company (2024) Smiths Group Plc Source HC 10 devices with a similar name Learn more about the data here Smiths Medical CADD administration Set with flow stop Model / Serial Model: CADD, Affected: Multiple …
MAUDE Adverse Event Report: SMITHS MEDICAL ASD, INC. CADD …
Web26 Nov 2024 · MMT was bought by the UK medical equipment firm Smith & Nephew in 2004 for £67m. After the success of this implant, DePuy brought its own version to the market … Web9 Dec 2024 · Class 1 Device Recall CADD Disposables: Date Initiated by Firm: December 09, 2024: Date Posted: January 30, 2024: Recall Status 1: Open 3, Classified: Recall Number: Z-0962-2024: Recall Event ID: ... Smiths Medical ASD Inc. 6000 Nathan Ln N Minneapolis MN 55442-1690: For Additional Information Contact: Sedgwick ksqy rapid city
Class 2 Device Recall CADD(TM) Medication Cassette Reservoir
Web28 Jan 2024 · Product Specifications CADD® Medication Cassette Reservoirs with Flow Stop Free-Flow Protection Notes: Must be used with CADD® Extension set. Tubing lengths are measured from output tubing. All tubing sets are not made with natural rubber latex. This page was last updated: Thursday January 28 2024 Web24 Mar 2024 · Smiths Medical ASD Inc. 6000 Nathan Ln N. Minneapolis MN 55442-1690. For Additional Information Contact. Dave Halverson. 763-383-3310. Manufacturer Reason. for Recall. Specific Pumps may exhibit intermittent performance in the AILD (Air in Line Detector) function. Web21 Dec 2024 · Recall of CADD Infusion Systems Impacts Many PH Patients A manufacturer recall of specific lots of CADD infusion systems recommends against using the affected systems for life-sustaining medication including brand and generic treprostinil (Remodulin) and epoprostenol (Veletri, Flolan). k-square-neighbors